Demonstrates effective photocatalytic dye degradation and solvent-free transformations in sustainable chemistry.
Developing solid catalysts to overcome multiple environmental challenges through a single system is an increasingly significant objective in sustainable chemistry. Here, we have synthesized a robust two-dimensional copper phosphonate framework (Cu-Pz) using 1-hydroxyethane1,1-diphosphonic acid (HEDP) and pyrazine, which enables photocatalytic dye degradation, solvent-free CO2 fixation and C–C bond formation heterogeneously. Owing to the variable Cu2+ coordination environments, Lewis-acidic Cu sites, and phosphonate-derived basic oxygen atoms, the framework activates both H2O2 and dissolved oxygen under blue-light irradiation, generating •OH and •O2– species through a synergistic photo-Fenton-like mechanism. This dual reactive oxygen species (ROS) pathway enables rapid degradation of a bulky diazo organic dye, i.e., Congo Red (CR), demonstrating efficient operation under narrow-band, low-energy light. We have observed 93% degradation of CR after 60 min of visible-light irradiation. As pseudo-first-order reaction kinetics are observed in photocatalytic degradation, we achieve a 0.04 min–1 rate constant for the degradation of CR. Beyond photocatalysis, the hybrid acid–base environment permits solvent-free Knoevenagel condensation and efficient CO2 cycloaddition with epoxides, underscoring the material’s inherent catalytic flexibility. We achieve 98% conversion with a 327 Turnover Number (TON) for CO2 fixation employing 0.03 mmol of catalyst and 98% conversion with a 274 TON for the Knoevenagel condensation with 0.025 mmol catalyst loading. The framework’s exceptional structural integrity and recyclability are maintained throughout all reactions, highlighting its robustness and usefulness. As a key step toward sustainable catalytic advancement, this multifunctional copper phosphonate catalyst provides an integrated, environmentally friendly method for CO2 utilization, organic synthesis, and dye degradation.
No takes yet. Share an insight, caveat, or question.
Maity et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: